We invite you to subscribe to our free webinar held on July 30 by clicking here: https://events.genndi.com/channel/cx-a-webinar.

Dr. Mathieu Frechin, Head of Quantitative Biology at Nanolive will introduce you the CX-A and its functionalities. He will outline the possibilities for parallelized experiments and image production capabilities.

In particular, the following topics will be covered:

Nanolive’s imaging technology
Presentation of the new hardware and software
Acquisition highlights showing data quality and new possibilities for label-free drug screening

Read our latest news

Label-free assessment of immunotherapies for liquid tumors

Jul 31, 2026 | News

From activation to target engagement and killing, Nanolive’s revolutionary technology enables the identification of the most effective therapeutic candidates for liquid tumors using live, label-free and advanced automated analysis of effector cell activity and function. Discover the case study data.

Simplifying drug delivery assessment: Industry perspectives

Jul 8, 2026 | News

Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.

Webinar – Investigating nanoparticle delivery with label-free live cell imaging

Jun 18, 2026 | Immuno-oncology, News

Watch our latest webinar, where Elizabeth Nelson shares research performed at the MIT Koch Institute for Integrative Cancer Research, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles…

More news